Latest / Ageless and Timeless Podcast® / Resetting Health: The Future of Food, Medicine, and Human Potential with guest Rob Verkerk

Transcript

Resetting Health: The Future of Food, Medicine, and Human Potential with guest Rob Verkerk · Ageless and Timeless Podcast®

• 0:09
  Speaker 1: Good morning everyone. This is Michelle Hughes from Ageless and Timeless.
• 0:14
  Speaker 1: My guest today is actually a brit He's from England
• 0:18
  Speaker 1: and his name is Rob Burkirk and he has been
• 0:23
  Speaker 1: in the health and wellness space for it well since
• 0:26
  Speaker 1: at least two thousand and two, in an active role
• 0:29
  Speaker 1: as the executive director.
• 0:32
  Speaker 2: I guess is that your title, Rob.
• 0:34
  Speaker 3: That is right, Michelle?
• 0:35
  Speaker 1: Yeah, of the Alliance for Natural Health International, correct.
• 0:42
  Speaker 3: Yeah, and the USA as well, and that's as well.
• 0:46
  Speaker 1: Yeah, that's why I said international because you added the USA.
• 0:49
  Speaker 1: You have someone here for about fifteen years and then
• 0:53
  Speaker 1: and you took over the responsibility for so you have
• 0:57
  Speaker 1: a really busy.
• 0:58
  Speaker 3: Life and we have we have another office in Amsterdam
• 1:02
  Speaker 3: as well. So yeah, so where are you?
• 1:06
  Speaker 2: Where are you today? Doing this podcast?
• 1:08
  Speaker 3: Today? I'm doing the podcast from the UK. I'm actually
• 1:11
  Speaker 3: a Dutch national, so I'm not a Dutch national and
• 1:17
  Speaker 3: next week I'll be back in the States, so literally
• 1:20
  Speaker 3: I moved backwards. It will Yeah, you know.
• 1:22
  Speaker 1: I do remember you telling me that, and you'd have
• 1:25
  Speaker 1: a Dutch last name anyway, so you have a British accent.
• 1:29
  Speaker 2: That's strange, I do.
• 1:30
  Speaker 3: Yeah, I was I was a victim of the British
• 1:34
  Speaker 3: boarding school system when my parents were living the other
• 1:37
  Speaker 3: side of the world.
• 1:38
  Speaker 1: Right, and you went to uh, you went to school
• 1:42
  Speaker 1: at Imperial College.
• 1:43
  Speaker 2: Right.
• 1:44
  Speaker 3: I did my my university. Yeah. I did my my
• 1:47
  Speaker 3: master's and PhD in post doc all at Imperial College.
• 1:52
  Speaker 1: How would you compare Imperial College to what what university
• 1:56
  Speaker 1: in the US would be comparable.
• 1:58
  Speaker 3: To Imperial, Oxford and Cambridge of the really the three
• 2:01
  Speaker 3: top universities in the UK. So the equivalent to Yale, Harvard,
• 2:05
  Speaker 3: you know.
• 2:06
  Speaker 1: Yeah, Okay, I went to Oxford. I'm proud to say
• 2:11
  Speaker 1: I had my little stint on the Thames and I
• 2:15
  Speaker 1: learned how to punt. Yeah. It was a graduate program
• 2:20
  Speaker 1: from where I went to undergraduate in the University of
• 2:24
  Speaker 1: Massachusetts in Amherst, Massachusetts.
• 2:27
  Speaker 2: I don't know if you know that, but it's a very.
• 2:28
  Speaker 1: Absolutely, very progressive school, and they had a program for
• 2:34
  Speaker 1: graduate students to go over to England and to Oxford.
• 2:38
  Speaker 1: I mean, so I was at Saint Hilda's College and
• 2:41
  Speaker 1: so we spend like a summer. It was about three
• 2:44
  Speaker 1: and a half months. It was really funny because when
• 2:47
  Speaker 1: I went over there, I was as skinny as a
• 2:49
  Speaker 1: reel and I mean, you know, like like people when
• 2:53
  Speaker 1: I came back to pick me up at the end,
• 2:55
  Speaker 1: they couldn't recognize me because we had been eating all.
• 2:59
  Speaker 1: You know, the food was so bad at those days
• 3:01
  Speaker 1: in Saint Hilda's.
• 3:03
  Speaker 2: So we went on the high you know, on the
• 3:05
  Speaker 2: main street, and we.
• 3:06
  Speaker 1: Would go to all the pastry shops and eat all
• 3:09
  Speaker 1: the cars. So we were certainly not your poster children
• 3:13
  Speaker 1: for healthy eating that at that time. But it was
• 3:17
  Speaker 1: because England didn't have or Oxford didn't have really good
• 3:22
  Speaker 1: quality food.
• 3:22
  Speaker 2: I know that's changed now and certainly.
• 3:24
  Speaker 3: Lunch and it's changed a lot. And of course the
• 3:27
  Speaker 3: other thing is your microbiome wouldn't have been adjusted to
• 3:32
  Speaker 3: you know, moving from a US dot to a European
• 3:35
  Speaker 3: or a UK diet. It wouldn't be adjusted, so that,
• 3:38
  Speaker 3: you know, that.
• 3:38
  Speaker 2: Is so true. And not only that, but I was
• 3:40
  Speaker 2: there in the summer, but I got the.
• 3:42
  Speaker 1: Worst nasal or you know, sinus and fetched and cold
• 3:49
  Speaker 1: that I'd ever had in my entire life. I've never
• 3:52
  Speaker 1: been so sick where I actually had to take antibiotics,
• 3:56
  Speaker 1: which I refused. You know, in my adult life, refuge
• 4:00
  Speaker 1: is to do unless it's a real crisis. Well, that
• 4:03
  Speaker 1: was a real crisis. So I think the weather, even
• 4:06
  Speaker 1: though it was warmer, it was still damp, and you know,
• 4:11
  Speaker 1: coming out of New England, even with the.
• 4:15
  Speaker 2: Humidity, it just I just wasn't used to it.
• 4:17
  Speaker 1: So that was an adjustment to the health and wellness.
• 4:22
  Speaker 3: You were not epigenetically adapted to the United Kingdom. There
• 4:26
  Speaker 3: you go as a result, Michelle. Yeah, and it's the
• 4:30
  Speaker 3: same people going the other way. You know, we're as
• 4:34
  Speaker 3: we become more and more global citizens. You could argue
• 4:36
  Speaker 3: that we've seen over the last fifty years or so,
• 4:41
  Speaker 3: food's becoming more and more similar. But still there are
• 4:45
  Speaker 3: pretty big adjustments.
• 4:47
  Speaker 1: So Rob start us off by telling us more about you.
• 4:51
  Speaker 1: Everybody always wants to know who is your guest, Michelle,
• 4:55
  Speaker 1: and why did you choose him or her to come
• 4:58
  Speaker 1: on your show? So give us some thumbnails of your background.
• 5:02
  Speaker 1: What influenced you to become who you are today.
• 5:07
  Speaker 3: Well, I've had a lifelong interest in really getting under
• 5:14
  Speaker 3: the covers of understanding what nature is and why it is,
• 5:18
  Speaker 3: even to the point of really trying to understand what
• 5:21
  Speaker 3: life is. You know, we I was giving a talk,
• 5:26
  Speaker 3: it was a couple of years ago in a huge
• 5:29
  Speaker 3: mansion in the UK. There were two of us who
• 5:31
  Speaker 3: were key speakers, and I had a load of top
• 5:33
  Speaker 3: doctors and scientists in the audience, and I was sitting
• 5:38
  Speaker 3: between two oak trees. I'd taken everyone out of the
• 5:41
  Speaker 3: lecture theater. It was a beautiful summer's afternoon, unlike the
• 5:44
  Speaker 3: weather that you had when you're an auto. And I said, look,
• 5:49
  Speaker 3: let's start by talking about life. What is life? And
• 5:54
  Speaker 3: I was a standard that amongst these doctors and scientists,
• 5:58
  Speaker 3: you know, people were very unsure or what life is?
• 6:01
  Speaker 3: You know that when when someone dies in chemistry, exactly
• 6:07
  Speaker 3: the same chemistry you know is still there. What happens
• 6:12
  Speaker 3: is an electrical and bioelectrical and electromagnetic impulses, including from
• 6:18
  Speaker 3: the heart and the brain stopped. But you know, bottom
• 6:21
  Speaker 3: line is we haven't got a clear view of it.
• 6:23
  Speaker 3: So I was a kind of kid growing up in
• 6:26
  Speaker 3: Africa that was fascinated by the jungle and by the bugs.
• 6:30
  Speaker 3: And I, you know, was being pushed during my schooling
• 6:35
  Speaker 3: years towards economics. And I thank god my grandmother in
• 6:40
  Speaker 3: Holland said why are you doing economics? She swayed me
• 6:43
  Speaker 3: back and I became an ecologist, so I carried on
• 6:47
  Speaker 3: studying nature. I then became very concerned about the way
• 6:53
  Speaker 3: corporations were interfering with our environment and with our choices.
• 7:00
  Speaker 3: I then spent ten years or so campaigning in Australia
• 7:04
  Speaker 3: on getting chemicals out of foods and agriculture and you know,
• 7:11
  Speaker 3: for termite control, you name it. That that was my
• 7:15
  Speaker 3: goal for ten years. I then went back into academia,
• 7:19
  Speaker 3: went back to Imperial College, did a master's and a PhD,
• 7:23
  Speaker 3: and then seven years of postdoc in the field of
• 7:26
  Speaker 3: sustainable agriculture, but looking particularly at you know, food quality
• 7:31
  Speaker 3: and how to produce the healthiest foods with the highest
• 7:35
  Speaker 3: nutrient values that didn't become inundated with disease and insects
• 7:41
  Speaker 3: and all the rest of it. The more I did
• 7:43
  Speaker 3: that work, the more I realized that the chemistries that
• 7:48
  Speaker 3: were required in a plant to avoid being ravaged by
• 7:53
  Speaker 3: pestant disease were the same chemistries that were beneficial to humans.
• 8:00
  Speaker 3: We eat small quantities of them. And at Imperial College
• 8:03
  Speaker 3: we had a big, you know, biology and ecology department,
• 8:06
  Speaker 3: but also a big medicine department. Whenever I would talk
• 8:10
  Speaker 3: to the medics, I was always amazed that they had
• 8:13
  Speaker 3: no interest or no understanding when I'd say, hey, look,
• 8:17
  Speaker 3: we're studying these really interesting glucascinholates, for example, in cruciferous vegetables,
• 8:23
  Speaker 3: and you know, we find in the cruciferus vegetables that
• 8:27
  Speaker 3: have high levels there's no need to use pesticides. These
• 8:30
  Speaker 3: things act as natural pesticides. But look, I've been reading
• 8:34
  Speaker 3: papers that say that when you consume small amounts of
• 8:37
  Speaker 3: these compounds, they're really protective against cancer. And I remember
• 8:42
  Speaker 3: specifically asking one of the top on cologists that Imperial
• 8:47
  Speaker 3: this question is about glucasinolates, and he looked at me
• 8:50
  Speaker 3: as if I had two heads and said, I don't
• 8:52
  Speaker 3: know what you're talking about. We do chemotherapy, radiotherapy and surgery.
• 8:57
  Speaker 3: And round about two thousand and two I was offered
• 9:02
  Speaker 3: a permanent I was offered permanent tenure at Imperial College,
• 9:06
  Speaker 3: and so I had to make a decision as to
• 9:09
  Speaker 3: whether to become an academic for the rest of my life,
• 9:14
  Speaker 3: build my research group, or go back to my campaigning roots.
• 9:21
  Speaker 3: And by this stage I was really concerned about how
• 9:25
  Speaker 3: nature was being completely stripped apart, and you know, I
• 9:29
  Speaker 3: wanted to create a linkage between those of us who
• 9:35
  Speaker 3: produce the healthiest foods on the planet and those who
• 9:38
  Speaker 3: produce the healthiest humans in other words, integritive medicine community.
• 9:45
  Speaker 3: And that's really what I've been building for the last
• 9:49
  Speaker 3: twenty odd years. And funnily enough, I'm going to Ohio
• 9:52
  Speaker 3: next week for a big thirty five strong expert panel
• 9:57
  Speaker 3: think tank to do exact that, to bring the region
• 10:01
  Speaker 3: AGG leaders together with the integrative medicine leaders so that
• 10:05
  Speaker 3: we can build strategy that links to you.
• 10:08
  Speaker 2: Know, you you are way ahead of your time.
• 10:11
  Speaker 1: I mean, honestly, this hasn't really even today you don't see.
• 10:17
  Speaker 2: I mean, I'm glad.
• 10:17
  Speaker 1: You're going to Ohio for thirty five people, but thirty
• 10:21
  Speaker 1: five people is a microcosm.
• 10:24
  Speaker 2: It is still so much lacking.
• 10:26
  Speaker 3: It's a think it's a think tank. So these are
• 10:29
  Speaker 3: the leaders in many leaders in the field, so that
• 10:32
  Speaker 3: we can really it's a closed door think tank invitations only.
• 10:36
  Speaker 4: Today's podcast is brought to you by Dimetria Products. Dimetria
• 10:40
  Speaker 4: is based in Carlsbad, California, and they manufacture ultra high
• 10:45
  Speaker 4: quality dietary supplements using chi Qi technology. Chi as you
• 10:53
  Speaker 4: probably know, is the energy that runs throughout our bodies
• 10:57
  Speaker 4: and is the basis of Chinese medicine. You use the
• 11:00
  Speaker 4: code ageless and get twenty percent off your order. I
• 11:04
  Speaker 4: highly recommend Gimetrio's products.
• 11:07
  Speaker 2: I personally use.
• 11:08
  Speaker 4: The complete aminos, the heart gems and the methusel Life
• 11:13
  Speaker 4: which is an RNA and DNA subling will spray. The
• 11:18
  Speaker 4: website to go to is www dot Jimetria dot com
• 11:24
  Speaker 4: slash gi Qi hyphen Technology and there you'll find out
• 11:31
  Speaker 4: more about this fascinating company, their products and the technology.
• 11:38
  Speaker 3: But you know, we were in the nineteen eighties, we
• 11:41
  Speaker 3: were fighting against life essay, you know people, the fact
• 11:46
  Speaker 3: that we still have to try and fight the fact
• 11:49
  Speaker 3: that we you know, back in nineteen ninety one, I
• 11:51
  Speaker 3: wrote one of the first papers that was showing deep
• 11:56
  Speaker 3: scientific concern for GMOs and the outdoor release GMOs in
• 12:01
  Speaker 3: our field site in the UK. Actually the first outdoor
• 12:04
  Speaker 3: trial of GMOs using l seed rape was conducted and
• 12:10
  Speaker 3: visiting US professor and myself pended a paper in a
• 12:14
  Speaker 3: fairly minor journal because we had to put it into
• 12:16
  Speaker 3: minor journal. Major journals wouldn't have accepted it. But called
• 12:19
  Speaker 3: Buyer Control News and we said, guys, this idea of
• 12:23
  Speaker 3: having a two hundred and fifty meter boundary zone between
• 12:28
  Speaker 3: a GM crop and a non GM crop, thinking you
• 12:30
  Speaker 3: can keep it clear is complete madness because we know
• 12:35
  Speaker 3: what gets caught up in the jet streams that moves across.
• 12:39
  Speaker 3: And we've been studying this with a feeds and you know,
• 12:43
  Speaker 3: tokings and other things. So this was lunacy. But right
• 12:47
  Speaker 3: now you know in fact that Trump administration is trying
• 12:51
  Speaker 3: to deregulate GMOs. They're trying to do the same that
• 12:55
  Speaker 3: they're going exactly in the wrong direction.
• 12:58
  Speaker 2: Oh my gosh, that's that's sharp with the elon. I
• 13:01
  Speaker 2: mean with Robert F. Kennedy.
• 13:03
  Speaker 3: Yes, you've got Kennedy who's got a view that's pretty
• 13:06
  Speaker 3: closely aligned. You know, we were in the in the
• 13:08
  Speaker 3: US Senate in January pushing to get Bobby Kennedy in.
• 13:14
  Speaker 3: Our legal counsel Jonathan Emoord and myself wrote a book
• 13:18
  Speaker 3: called in fact we can we can call that out
• 13:23
  Speaker 3: but the MAHA Mandate reversing America's Chronic disease Epidemic. So
• 13:29
  Speaker 3: we wrote a book and distributed to every single Senator.
• 13:33
  Speaker 3: Bobby gets in, but you you will know that his
• 13:38
  Speaker 3: his hands are largely tired, and you've got many opposing forces.
• 13:43
  Speaker 3: Donald Trump wants to do stuff that's good for business,
• 13:46
  Speaker 3: and sometimes it doesn't matter which kind of business chemical businesses,
• 13:51
  Speaker 3: pharmaceutical businesses are, you know, which we would argue two
• 13:56
  Speaker 3: very very concerning businesses that are I'm very I'm.
• 14:01
  Speaker 1: Very shocked about that because it can't seem like the
• 14:04
  Speaker 1: drug industry and then of course the food industry were
• 14:08
  Speaker 1: targets right at the very beginning in January when they
• 14:11
  Speaker 1: had that meeting with RFK and the top people from
• 14:16
  Speaker 1: the you know, even Monsanto and Bear and Abbott and
• 14:20
  Speaker 1: all the you know, the big guys and the General Mills,
• 14:24
  Speaker 1: General Foods, Procter and Gamble. They were all there, and
• 14:27
  Speaker 1: you know, and they were being challenged. But apparently that
• 14:31
  Speaker 1: hasn't held wait for going forward with respect to what
• 14:37
  Speaker 1: you're just talking about.
• 14:38
  Speaker 3: You know that there's progress in some directions, and there's
• 14:43
  Speaker 3: progress and opposite directions. You know, perhaps you can use
• 14:46
  Speaker 3: as an analogy one of the reasons for the breakdown
• 14:50
  Speaker 3: in the relationship between Donald Trump and Elon Musk. Yes,
• 14:55
  Speaker 3: the savings that that Elon must work hard to create
• 14:58
  Speaker 3: through DOGE. It's immediately undone by the big beautiful bill.
• 15:05
  Speaker 3: So this is quite typical of the characteristics of this
• 15:09
  Speaker 3: administration where you've got some stuff that is really moving
• 15:12
  Speaker 3: in the right direction of other stuff going in the
• 15:15
  Speaker 3: opposite direction, so not coherent.
• 15:18
  Speaker 1: Are you saying that the US is going to be
• 15:21
  Speaker 1: the leader waving the flag for whatever happens in the
• 15:24
  Speaker 1: future with respect to the work that you're.
• 15:28
  Speaker 3: Doing, Well, yeah, Look, the opportunity is huge. I mean,
• 15:33
  Speaker 3: having Bobby Kennedy heading up HHS is a massive opportunity.
• 15:39
  Speaker 3: We are actually developing twenty eight initiatives, eight of them
• 15:45
  Speaker 3: we've already unleashed this year that are going to be
• 15:49
  Speaker 3: creating a seed change to regulation around food, drugs, dietary supplements,
• 15:57
  Speaker 3: health products generally. So we are, you know, pushing very
• 16:03
  Speaker 3: very hard to use constitutional grounds case law that there
• 16:07
  Speaker 3: was a phenomenal change in underlying case law when the
• 16:14
  Speaker 3: Chevron doctrine that was passed in nineteen eighty four. That
• 16:18
  Speaker 3: really was the vehicle that US agencies government agencies were
• 16:23
  Speaker 3: using to overreach, whether it's the FDA, the FDC, the EPA,
• 16:28
  Speaker 3: they were able to use any point of legal ambiguity
• 16:33
  Speaker 3: and go, do you know what we will make the
• 16:35
  Speaker 3: determination so that that's how they overreach, that's how they
• 16:39
  Speaker 3: go beyond the law, and that was overturned on the
• 16:43
  Speaker 3: twenty eighth of June last year. And that's one of
• 16:47
  Speaker 3: the reasons that Jonathan has joined us. Jonathan Emoud also
• 16:51
  Speaker 3: known as the FDA Dragon Slayer because he's won more
• 16:55
  Speaker 3: cases against the FDA than any other attorney fourteen and county.
• 17:01
  Speaker 3: He joined our team. He said, Rob, you know, we've
• 17:05
  Speaker 3: worked together for twenty years. He's six of his fourteen
• 17:09
  Speaker 3: wins have been on behalf of our organization. But now
• 17:14
  Speaker 3: he's in house and we're you know, in the space
• 17:17
  Speaker 3: of a year, we got twenty eight initiatives that we're
• 17:20
  Speaker 3: using to really bust open the market the ability to
• 17:26
  Speaker 3: communicate scientific truth that the amount of censorship that has
• 17:31
  Speaker 3: built up over the decades is I mean that this control,
• 17:37
  Speaker 3: this monopolization that the drug companies have had even over nutrients,
• 17:42
  Speaker 3: you know, and disease claims. So one of our actions
• 17:46
  Speaker 3: is using a particular clause in the FDA Modernization Act
• 17:51
  Speaker 3: that Jonathan wrote many years ago, basically says if a
• 17:56
  Speaker 3: health agency health authority makes an authoritative claim around a
• 18:03
  Speaker 3: nutrient disease relationship. So you know, one of the ones
• 18:06
  Speaker 3: that people know a lot about that's now authorized is
• 18:11
  Speaker 3: the use of folate or folic acid the risk of
• 18:15
  Speaker 3: neural tube defects. But if we're going to be looking
• 18:19
  Speaker 3: at the ability of cocuminoids, for example, some of these
• 18:26
  Speaker 3: compounds in tumeric to cancer risks, there's a huge amount
• 18:30
  Speaker 3: of data on that. The drug companies are busy working
• 18:32
  Speaker 3: on it. But what happens is that government authorities like
• 18:38
  Speaker 3: the Office of Doughtary Supplements within the NIH, on their
• 18:43
  Speaker 3: website actually say that, But if you're a commercial customer
• 18:48
  Speaker 3: you want to sell a doutary supplement containing that product,
• 18:52
  Speaker 3: you can't put the claim on your You're can only
• 18:55
  Speaker 3: put a structure function claim on your label. Now, we've
• 18:58
  Speaker 3: got a list of about one hundred and fifty key
• 19:01
  Speaker 3: claims nutrient disease claims that health authorities, primarily the NIH,
• 19:09
  Speaker 3: are making about nutrients and diseases, and basically, using this
• 19:12
  Speaker 3: clause in the FDA Modernization Act, we're petitioning the FDA
• 19:16
  Speaker 3: to say, guys, we want all of those to be
• 19:20
  Speaker 3: able to be used in public speech, including commercial speech.
• 19:24
  Speaker 3: Now that for the first time take away this control
• 19:30
  Speaker 3: by the drug companies to control speech, so they are
• 19:33
  Speaker 3: the only ones who can talk about drugs in relation
• 19:36
  Speaker 3: to disease. We want to be able to talk about
• 19:38
  Speaker 3: nutrients or food in relation disease. If we can't do that,
• 19:43
  Speaker 3: we cannot make America healthy again.
• 19:46
  Speaker 2: You know, it.
• 19:47
  Speaker 1: Seems like countries like Switzerland as an example in Austria,
• 19:52
  Speaker 1: there's some far ahead in terms of their belief in natural, functional,
• 19:58
  Speaker 1: integrative medicine, and yet they don't ever get used as
• 20:02
  Speaker 1: the examples for countries like the US or Great Britain
• 20:07
  Speaker 1: as role models to follow some of their precepts.
• 20:11
  Speaker 2: So why is that?
• 20:14
  Speaker 3: Basically because the essentially that the drug companies and the
• 20:18
  Speaker 3: food companies and the agrochemical companies used two major bases
• 20:22
  Speaker 3: in the industrialized world. One is Europe, the EU. And
• 20:26
  Speaker 3: you've got to remember, up until Brexit, the UK was
• 20:30
  Speaker 3: one of the key drafters of EU legislation. Most of
• 20:34
  Speaker 3: the legislation run drugs, agrochemicals GMOs has been created by
• 20:39
  Speaker 3: the Brits. So now that you've got Brexit, it really
• 20:42
  Speaker 3: is one and the same thing. So you've got that
• 20:44
  Speaker 3: as one major area and then the US is the other.
• 20:48
  Speaker 3: And essentially what's happened over the last eighty or so
• 20:52
  Speaker 3: years is that we've developed a corporatetocracy. This is where
• 20:57
  Speaker 3: essentially very large corporations into into the functioning of government
• 21:03
  Speaker 3: and are no longer separate entities, and they work in
• 21:06
  Speaker 3: their joint interest. The government wants to control and corporations
• 21:12
  Speaker 3: want power and control, and that's one of the reasons
• 21:16
  Speaker 3: we've seen extreme censorship. It's one of the reasons we've
• 21:19
  Speaker 3: seen the licensing system for drugs develop as a pay
• 21:26
  Speaker 3: to play system. You pay your money and then you're
• 21:29
  Speaker 3: allowed to call your products safe and effective, even if
• 21:35
  Speaker 3: the scientific data says otherwise that it's not safe. We
• 21:40
  Speaker 3: know that drugs can be the third leading cause of
• 21:42
  Speaker 3: death in Western society Peter Gotcher and others, and if
• 21:47
  Speaker 3: it's ineffective, and we know from multiple publications BMJ Clinical Evidence,
• 21:52
  Speaker 3: before it was closed down, had evaluated three thousand mainstream
• 21:59
  Speaker 3: interventions and found that only ten percent of them had
• 22:02
  Speaker 3: been scientifically found to be beneficial.
• 22:04
  Speaker 2: So from why were they closed down? I think I
• 22:08
  Speaker 2: know the answer.
• 22:10
  Speaker 3: Because we were exactly very good rhetorical question, Michelle. It
• 22:14
  Speaker 3: is because all of us were using that as evidence
• 22:17
  Speaker 3: for the fact that the drug regulation story system does
• 22:21
  Speaker 3: not work. But we're in the middle of major academic
• 22:26
  Speaker 3: studies we've published. We've submitted a major paper that looks
• 22:31
  Speaker 3: at drug and food definitions in eighteen different jurisdictions in
• 22:38
  Speaker 3: the world over one hundred and twenty year period, and
• 22:40
  Speaker 3: that's in peer review at the moment. And what it
• 22:44
  Speaker 3: shows incredibly clearly when you take a bird's eye view
• 22:48
  Speaker 3: of what's happened over the last one hundred and twenty years,
• 22:50
  Speaker 3: is that originally food and drug law was out there
• 22:54
  Speaker 3: to protect us, the city consumer. Over this last one
• 22:58
  Speaker 3: hundred and twenty years, it's shifted. Now it protects the corporations.
• 23:04
  Speaker 3: And we've got a situation where food is killing us
• 23:07
  Speaker 3: and drugs are killing us, the two things.
• 23:10
  Speaker 1: You know, Robert, that is such a sobering statement, but
• 23:15
  Speaker 1: it's so true.
• 23:16
  Speaker 2: I mean, the.
• 23:17
  Speaker 1: Industrial revolution changed everything in terms of the priorities and
• 23:22
  Speaker 1: the concern for the health of the individual versus the
• 23:25
  Speaker 1: health or the bottom line of the corporate entity. So
• 23:30
  Speaker 1: and when we say corporate, we're talking about, you know,
• 23:33
  Speaker 1: not just the corporations, but the medical establishment and the
• 23:38
  Speaker 1: government entities that are controlled. So I mean it is
• 23:42
  Speaker 1: like a three pronged monster at least three is there
• 23:48
  Speaker 1: would there be any country that you would use as
• 23:52
  Speaker 1: a role model for what you're trying to achieve with
• 23:56
  Speaker 1: your alliance.
• 23:58
  Speaker 3: You know, there isn't really a country that has got
• 24:02
  Speaker 3: it all right. I mean, it's really interesting when you
• 24:05
  Speaker 3: look at small generally, you have to look to small
• 24:07
  Speaker 3: countries where they have many things more right, Places like
• 24:11
  Speaker 3: Costa Rica are developing some pretty interesting regulatory systems because
• 24:17
  Speaker 3: they really understand the power of nature. I mean, one
• 24:22
  Speaker 3: of the reasons that we don't see it in any significant,
• 24:25
  Speaker 3: you know, large country is that the the industrial complex,
• 24:30
  Speaker 3: whether it's the censorship industrial complex, the agricultural industrial, medical
• 24:35
  Speaker 3: industrial complex, these complexes have become so dominant that they
• 24:40
  Speaker 3: use regulation as a mechanism to essentially further their own ends. So,
• 24:48
  Speaker 3: you know, we saw it during COVID when you know
• 24:53
  Speaker 3: a few countries Zambia, Tanzania decided to reject the receipt
• 24:59
  Speaker 3: of COVID vaccines and immediately they've faced penalties. I mean
• 25:04
  Speaker 3: that this is the way in which.
• 25:07
  Speaker 2: They were punished.
• 25:08
  Speaker 3: They were punished. So the incentive to be able to
• 25:13
  Speaker 3: stand out there and go against the flow is questionable
• 25:19
  Speaker 3: and you know, this is this is I think one
• 25:20
  Speaker 3: of the reasons that there was so much excitement around
• 25:24
  Speaker 3: the arrival of Donald Trump. You know, the reasons he
• 25:27
  Speaker 3: got in because people thought he's not from that system.
• 25:31
  Speaker 3: Let's see what he can do. And so you know,
• 25:36
  Speaker 3: hopefully that that there is you know, COVID in many respects,
• 25:41
  Speaker 3: has been backfired on the system. They wanted to use
• 25:46
  Speaker 3: it as a catalyze more control. What it's done instead
• 25:52
  Speaker 3: is it's woken a whole bunch of people who were asleep,
• 25:57
  Speaker 3: you know, on the tiller.
• 25:59
  Speaker 1: So and particularly it only you know, we don't need
• 26:02
  Speaker 1: to get into the vaccine parte, just to you know,
• 26:05
  Speaker 1: it would be irresponsible not to mention that the vaccine
• 26:10
  Speaker 1: has really caused an awakening because it was done within
• 26:14
  Speaker 1: such a speedy time to you know, basically it was
• 26:17
  Speaker 1: done with good intention, but there has never been a
• 26:21
  Speaker 1: vaccine that's developed and produced and used so quickly in history.
• 26:27
  Speaker 2: So you know, it usually goes the other way. It's
• 26:29
  Speaker 2: like a ten year period, but this was in what.
• 26:32
  Speaker 3: Nine months, and of course it was it has been misclassified.
• 26:37
  Speaker 3: We are considering illegal action on its classification because it's
• 26:43
  Speaker 3: really not a vaccine at all. I mean, it's only
• 26:46
  Speaker 3: a vaccine because they have modified the definition of a vaccine.
• 26:50
  Speaker 3: So a vaccine is any substance that modifies the you know,
• 26:56
  Speaker 3: the immune response, and basically, you know, generally speaking, it's
• 27:01
  Speaker 3: it's it's only a very small part of the immune response.
• 27:04
  Speaker 3: Typically it's an antibody response. You can equally argue that
• 27:10
  Speaker 3: there are a whole range of natural substances that also
• 27:14
  Speaker 3: fulfill the definition of a vaccine, whereas the average person's
• 27:19
  Speaker 3: interpretation of a vaccine. The only way in which you
• 27:22
  Speaker 3: can argue that everyone should be vaccinated is if a
• 27:27
  Speaker 3: vaccine actually reduced a transmission and establishment, yeah, it was
• 27:33
  Speaker 3: established very early on. This one doesn't. So basically a
• 27:37
  Speaker 3: medical treatment and and it is also a gene therapy product,
• 27:44
  Speaker 3: so you know, and of course, what they've done, I
• 27:48
  Speaker 3: mean what they've done in the UK in the recent
• 27:51
  Speaker 3: amendment to the Medicines Regulations that passed a law to
• 27:55
  Speaker 3: make it illegal to call it a gene therapy product,
• 27:59
  Speaker 3: because everyone's calling the gene therapy product. So that this
• 28:02
  Speaker 3: is the way in which legislation has used to control
• 28:06
  Speaker 3: the space.
• 28:07
  Speaker 1: So you know, you've had a lot of resistance just
• 28:11
  Speaker 1: you know, obviously because of what you're doing, you're going
• 28:13
  Speaker 1: against the you know, industrial complex. But I noticed on Wikipedia,
• 28:19
  Speaker 1: which I always thought was pretty reliable, but yet they
• 28:22
  Speaker 1: even said there something that was kind of pejorative about
• 28:26
  Speaker 1: your work, like, oh, he went against science, you know,
• 28:30
  Speaker 1: And so how do you deal with those kinds of
• 28:33
  Speaker 1: challenges in your professional life which you wear.
• 28:37
  Speaker 3: It as a badge of honor in essence, I mean, honestly,
• 28:43
  Speaker 3: and everything that we do, we we call what we
• 28:46
  Speaker 3: do good science and good law. I have been astonished
• 28:51
  Speaker 3: over the last five years, particularly since COVID, but it
• 28:54
  Speaker 3: was happening. It was part of a creep that was
• 28:57
  Speaker 3: going on well before that. The deterior and the quality
• 29:01
  Speaker 3: of science, it's staggering. I read things in major journals like,
• 29:06
  Speaker 3: you know, BMJ, probably less so it's is now one
• 29:10
  Speaker 3: of the best medical journals, I feel. But the Lancet
• 29:14
  Speaker 3: New England Journal Medicine JAMMA that is astonishing. The abstract
• 29:22
  Speaker 3: does not reflect accurately the results. The methodology is not
• 29:30
  Speaker 3: clear enough for someone to be able to duplicate the
• 29:33
  Speaker 3: experiment because they leave a whole bunch of data aut
• 29:36
  Speaker 3: The statistical significance is interpreted as being equivalent to biological significance,
• 29:44
  Speaker 3: when actually they're only finding statistical significance because they're looking
• 29:50
  Speaker 3: at a randomized controlled trial in which the internal validation
• 29:53
  Speaker 3: standards are so tight, there's so little other sources of variation.
• 29:58
  Speaker 3: They just get a statistic the signific significant result. But
• 30:02
  Speaker 3: they make the assumption that if you take that same
• 30:05
  Speaker 3: intervention into the real world, you'll get the same result.
• 30:09
  Speaker 3: And this is the difference between efficacy, which you measure
• 30:13
  Speaker 3: under experimental conditions in a randomized control trial, and effectiveness.
• 30:17
  Speaker 3: So I've been a critic of that system. I've exposed
• 30:23
  Speaker 3: a lot of it. And the only tactic that they use.
• 30:27
  Speaker 3: All of us who have stood up and been dissenters
• 30:32
  Speaker 3: of the mainstream scientific process all accused of engaging in pseudoscience.
• 30:39
  Speaker 2: That's what they said about you.
• 30:40
  Speaker 3: So and once you then enter the realms. We have
• 30:44
  Speaker 3: a big interest in biophysics, and you know as as
• 30:50
  Speaker 3: applied to healthcare. So if you look at, say the
• 30:53
  Speaker 3: development of frequency devices in healthcare, this is one of
• 31:00
  Speaker 3: the big emerging areas of medicine. But of course it's
• 31:04
  Speaker 3: very threatening to drug companies, it's very threatening to some
• 31:09
  Speaker 3: of the mainstream medical device companies and it's pushed into
• 31:14
  Speaker 3: it's marginalized essentially, So as soon as you deal with
• 31:18
  Speaker 3: those more fringe areas, that should be encouraged, because that is,
• 31:23
  Speaker 3: you know, as Einstein said, the next frontier of medicine
• 31:26
  Speaker 3: will be frequency. We are frequency beings. And you know,
• 31:33
  Speaker 3: as if biochemistry and molecular biology and genetics was the
• 31:37
  Speaker 3: end game, of course it's not the end game. It's
• 31:40
  Speaker 3: part of a much bigger picture. And we are early
• 31:43
  Speaker 3: in our journey in understanding even how humans function, and
• 31:48
  Speaker 3: we are ultimately we've got to be very, very open.
• 31:52
  Speaker 3: So to be a good scientist, to be even a
• 31:54
  Speaker 3: skeptic scientist, you have to have an incredibly open mind.
• 31:59
  Speaker 3: And one of the big disturbing changes in the scientific
• 32:05
  Speaker 3: mainstream is that so many of these scientists have become
• 32:08
  Speaker 3: incredibly narrow minded. That's not good for science.
• 32:11
  Speaker 1: Well knowing that, but these studies are often funded by
• 32:14
  Speaker 1: the very people that are intended to gain by the results.
• 32:18
  Speaker 1: So how can we say that it's true science if
• 32:21
  Speaker 1: it's if it's not, if it's not.
• 32:24
  Speaker 3: Abductive Because the part of the part of being narrow
• 32:28
  Speaker 3: minded is to make sure that you do things that
• 32:31
  Speaker 3: please your sponsor your funder and essentially the whole scientific
• 32:37
  Speaker 3: system is controlled by money. Now nature doesn't do that.
• 32:41
  Speaker 3: You know, We've always in my academic work we would
• 32:44
  Speaker 3: always use really complex ecosystems as our learning grounds. So
• 32:50
  Speaker 3: if we look at jungles, rainforests, and coral reefs, these
• 32:54
  Speaker 3: are the most complex systems we know about, and the
• 32:58
  Speaker 3: interchange of energy, the exchange, I mean, there's still a
• 33:02
  Speaker 3: bunch of organisms eating one another, but out of all
• 33:06
  Speaker 3: of that is a degree of coordination and feedback that
• 33:10
  Speaker 3: yields something that is stable, sustainable, beautiful. And you know,
• 33:17
  Speaker 3: we as humans, we go in with a very limited
• 33:20
  Speaker 3: understanding of this. And right now we are I believe
• 33:24
  Speaker 3: that a bifurcation point in human evolution because we're now
• 33:29
  Speaker 3: beginning to meddle with our own genome where we seem
• 33:33
  Speaker 3: to be happy doing that. We are happy to turn
• 33:38
  Speaker 3: the human body into a pharmaceutical factory, which is what
• 33:41
  Speaker 3: happens when you use technologies like mr and a body
• 33:45
  Speaker 3: to produce whatever medicine you wanted to do. mRNA is
• 33:51
  Speaker 3: seen as a very very expansive platform for pharmaceutical industry,
• 33:57
  Speaker 3: which is why they want nothing to be said negative
• 34:00
  Speaker 3: about it, which is why it was a big cover
• 34:02
  Speaker 3: up on the number of people that have been adversely
• 34:05
  Speaker 3: affected by COVID chaps go ahead, no, no, no. So
• 34:10
  Speaker 3: so we're at this this, this point where where we
• 34:13
  Speaker 3: should be having a public debate over are we going
• 34:18
  Speaker 3: to accept a kind of transhuman future in which we
• 34:22
  Speaker 3: blur the you know, the the the interface between natural biology,
• 34:29
  Speaker 3: if you can call it natural biology and synthetic biology
• 34:34
  Speaker 3: and technology. And that's beginning to happen. Censorship prevented any
• 34:40
  Speaker 3: public discussion and and now you can see they're trying
• 34:43
  Speaker 3: to deregulate you know, crisper technology, gene editing, what I
• 34:49
  Speaker 3: called GMO version two, and you know, the average person thinks, well,
• 34:55
  Speaker 3: you know, governments wouldn't allow something that was dangerous. It
• 34:58
  Speaker 3: must all be tested. We keep hearing people saying that
• 35:01
  Speaker 3: it's safe, just like COVID vaccines were safe, but there's
• 35:06
  Speaker 3: been no public discussion.
• 35:08
  Speaker 1: And then what about the future with technology, you know,
• 35:13
  Speaker 1: the very things that you just mentioned, But then adding
• 35:15
  Speaker 1: in biotech and AI and you know where we're heading
• 35:20
  Speaker 1: is is that are they selling their soul those companies?
• 35:23
  Speaker 1: It looks like biotech is already in the you know,
• 35:26
  Speaker 1: in the in the hands of the drug companies, so
• 35:30
  Speaker 1: they're owned by drug companies.
• 35:32
  Speaker 2: Yeah, already again is what about EI.
• 35:37
  Speaker 3: Well, drug companies are certainly buying up many small biotech companies.
• 35:44
  Speaker 3: They use the small innovative biotech companies as they're R
• 35:48
  Speaker 3: and D. No, they don't want to spend money internally.
• 35:52
  Speaker 3: Big drug companies don't spend money anymore, and the same
• 35:55
  Speaker 3: amount of money the same investment in R and D
• 35:59
  Speaker 3: as they used to go and snap up other biotech
• 36:02
  Speaker 3: firms and then merge their operations.
• 36:04
  Speaker 1: They justify their prices by the fact that their R
• 36:07
  Speaker 1: and D costs are so high.
• 36:08
  Speaker 2: So yeah, you're saying R and D class. That means
• 36:11
  Speaker 2: the acquisition of.
• 36:12
  Speaker 1: These little biotech companies, not the R and D that
• 36:15
  Speaker 1: they would have done roally.
• 36:18
  Speaker 3: Where So AI AI to come back the second body
• 36:23
  Speaker 3: of question, AI is absolutely here to say to stay.
• 36:27
  Speaker 3: I personally have no problem with AI when it's used externally.
• 36:32
  Speaker 3: When it's used as an intelligent system in the same
• 36:35
  Speaker 3: way that we use a computer as an intelligent system,
• 36:39
  Speaker 3: it is incredibly helpful to process vast amounts of data
• 36:44
  Speaker 3: that allow us to get information much quicker and be
• 36:50
  Speaker 3: able to analyze and interpret data, which is what science
• 36:53
  Speaker 3: is all about. So an incredibly valuable tool. However, in
• 36:58
  Speaker 3: the wrong hands or in the wrong place is you know.
• 37:01
  Speaker 3: So let's look at, say, the use of AI to
• 37:07
  Speaker 3: create a downloadable synthetic memory, which is one of the ways,
• 37:12
  Speaker 3: which is it's being contemplated, it's being used. Now that
• 37:17
  Speaker 3: for me is where it's crossed the line. It's across
• 37:19
  Speaker 3: the line because you know that that really fits perfectly
• 37:25
  Speaker 3: well with you know class Schwab's view has put forward
• 37:28
  Speaker 3: in his twenty seventeen book The Fourth Industrial Revolution, where
• 37:32
  Speaker 3: he looks at twenty three different technologies. You know, if
• 37:37
  Speaker 3: you use AI to create designer babies, for example, I
• 37:43
  Speaker 3: would have a problem with that. You no longer allow
• 37:48
  Speaker 3: this extraordinary process that nature uses to decide what's good
• 37:54
  Speaker 3: and bad. I mean, nature exchanges genetic material all the time.
• 37:58
  Speaker 3: It decides through natural selection processes and evolution, what should stay,
• 38:04
  Speaker 3: what should change, what should adapt, what should become more
• 38:07
  Speaker 3: resilient less resilient. But once you start using essentially machine
• 38:15
  Speaker 3: learning and AI to do that, you're susceptible to programs
• 38:21
  Speaker 3: that are produced by people who have specific goals.
• 38:25
  Speaker 2: Inn and one of those is controlled.
• 38:29
  Speaker 3: Yeah, one of those is absolutely control. So yeah, I
• 38:34
  Speaker 3: think we have to watch AI like a hawk. I
• 38:37
  Speaker 3: think it's I think to be anti AI makes no
• 38:41
  Speaker 3: sense either, exactly, Yeah, cautiously.
• 38:46
  Speaker 1: The point though, is that if you look at AIS,
• 38:51
  Speaker 1: if you want to take it to a spiritual level,
• 38:53
  Speaker 1: the decision between good and evil, and humanity has demonstrated
• 38:59
  Speaker 1: they have a tougher time choosing between good and evil
• 39:02
  Speaker 1: and their everyday practices. So now we're adding another layer,
• 39:06
  Speaker 1: a technological layer that is also forcing us to pick.
• 39:09
  Speaker 2: Between good and evil, because there's a plenty of evil
• 39:12
  Speaker 2: that AI can can create, but there's also plenty of good,
• 39:17
  Speaker 2: as you've just said.
• 39:18
  Speaker 3: So I find it really interesting to pose questions to
• 39:24
  Speaker 3: AI models or machine learning models. Many of them are
• 39:27
  Speaker 3: not true AI, the more machine learning. But if you
• 39:29
  Speaker 3: pose questions across different platforms, so you ask Grock versus Google,
• 39:35
  Speaker 3: Gemini versus Chatter GBT, for example, you'd be amazed at
• 39:41
  Speaker 3: the differences and results. And you can see that Google,
• 39:45
  Speaker 3: in my mind, provides the most standard status quo type
• 39:51
  Speaker 3: response consistently. You know, if you look at Google, one
• 39:56
  Speaker 3: of the largest, you know, tech platforms in world, many
• 40:02
  Speaker 3: of the people involved with it are big on control,
• 40:05
  Speaker 3: control of information. They you know, Google's and YouTube's medical
• 40:11
  Speaker 3: misinformation policy is absolute madness, you know, basically, unless you're
• 40:15
  Speaker 3: saying what the governments say, what the FDA, the NIH say.
• 40:20
  Speaker 3: They've taken off recent very recently, they've taken off the
• 40:25
  Speaker 3: World Health Organization off their their medical misinformation policy, which
• 40:31
  Speaker 3: is interesting.
• 40:32
  Speaker 2: I didn't know that.
• 40:34
  Speaker 3: We just saw it a couple of weeks ago when
• 40:36
  Speaker 3: we checked, because we've been campaigning against Google because of
• 40:39
  Speaker 3: that policy. Basically, they said, if a information around medicine,
• 40:46
  Speaker 3: whether it's disease treatment or prevention, if it does not
• 40:51
  Speaker 3: comply with the views and perspectives of local national health
• 40:57
  Speaker 3: authorities or the WHO, it's just allowed. So that was
• 41:02
  Speaker 3: a mechanism that they could censor almost anything if it
• 41:05
  Speaker 3: if it didn't support a WHO kind of CDC kind
• 41:09
  Speaker 3: of view. So that that that has changed a little bit,
• 41:14
  Speaker 3: but that's no doubt the result of the Trump administration.
• 41:18
  Speaker 1: So tell me more about why the United States of America,
• 41:24
  Speaker 1: the leading industrial nation in.
• 41:26
  Speaker 2: The world, is number eighty in healthcare.
• 41:32
  Speaker 1: How did we get to be so low on the
• 41:36
  Speaker 1: ratings and that and how do those ratings get established
• 41:40
  Speaker 1: in the.
• 41:41
  Speaker 2: In the first place.
• 41:43
  Speaker 3: Okay, So so the this is a the major organization
• 41:51
  Speaker 3: that is involved, funded by Bill Gates, that has been
• 41:54
  Speaker 3: behind the global burden of disease studies and the same Actually,
• 42:00
  Speaker 3: what they're looking at is healthy life years, health adjusted
• 42:04
  Speaker 3: life years, so it's healthy life expectancy, So you can
• 42:09
  Speaker 3: look at longevity. Longevity is a useful marker for all
• 42:13
  Speaker 3: of us who are interested in anti aging. But what's
• 42:16
  Speaker 3: really interesting is to look at how many years do
• 42:20
  Speaker 3: we remain completely healthy, free from morbidities or comorbidities. And
• 42:26
  Speaker 3: in those terms, the IHME data puts America eightieth, with
• 42:35
  Speaker 3: the view that it will by twenty fifty move below
• 42:41
  Speaker 3: one hundredth in the global rankings. So not only puts
• 42:45
  Speaker 3: it at the bottom of all industrialized high income countries,
• 42:49
  Speaker 3: it puts it at the bottom of many or very
• 42:53
  Speaker 3: low down in the list of medium income countries. Yet
• 42:57
  Speaker 3: the US spends more money on healthcare it sets of
• 43:00
  Speaker 3: twelve dollars per capita per annum than any other country
• 43:06
  Speaker 3: by long range. So you know, if you look at
• 43:08
  Speaker 3: say countries like Peru, they do better than the US.
• 43:13
  Speaker 3: So what's causing it, Well, it is the usual culprits,
• 43:21
  Speaker 3: But trying to get really firm data on how it
• 43:26
  Speaker 3: all fits together and which is more important than the
• 43:28
  Speaker 3: other is tough. But it is the food and the
• 43:32
  Speaker 3: food quality, but it's not it's also how Americans eat.
• 43:38
  Speaker 3: So you know a lot of people thinking about the
• 43:40
  Speaker 3: what what you put into your mouth every day, but
• 43:43
  Speaker 3: you've got to think of the how. So the how
• 43:46
  Speaker 3: is going to be how frequently do you eat, how
• 43:49
  Speaker 3: much do you eat? When you eat? What is the
• 43:52
  Speaker 3: composition and the quality of the foods that you are consuming.
• 43:57
  Speaker 3: When are you consuming sweet foods in relation to savory foods?
• 44:02
  Speaker 3: And I'll just give you an example of you you
• 44:05
  Speaker 3: know this practice of people in Western societies but also
• 44:08
  Speaker 3: many Eastern societies of eating sweeter things after a main meal.
• 44:13
  Speaker 3: What that does when you've got the protein, fats, and
• 44:15
  Speaker 3: carbs in your diet and then you have something sweet
• 44:17
  Speaker 3: and immediately afterwards, you buffer your insulin response, You blunt
• 44:22
  Speaker 3: that insulin response. So whereas if you get hungry in
• 44:26
  Speaker 3: the middle of the morning, middle of the afternoon, you go,
• 44:28
  Speaker 3: all my energy levels are going, and you put in
• 44:30
  Speaker 3: biscuits or chocolate or candy or anything like that, or
• 44:36
  Speaker 3: you take you know, sweetened sodas. It's a nightmare for
• 44:42
  Speaker 3: your blood sugar. And because insulin resistance, which underpins metabolic
• 44:51
  Speaker 3: disease and type two diabetes and obesity, is to do
• 44:55
  Speaker 3: with the frequency of insults of high blood sugar and
• 45:00
  Speaker 3: raised insulin. If you then have three main meals a
• 45:05
  Speaker 3: day and then you consume snacks in between, so that
• 45:08
  Speaker 3: you maybe six seven eight eating episodes per day, imagine
• 45:15
  Speaker 3: you keep on insulting your cells and the cell membranes,
• 45:19
  Speaker 3: making them more and more insulin resistance. So and we
• 45:26
  Speaker 3: think about how we eat well, chewing thirty times every
• 45:32
  Speaker 3: mouthful to allow the digestive enzymes to synchronize, so all
• 45:38
  Speaker 3: the amlasers released in the salivary enzymes, and you've got
• 45:42
  Speaker 3: sufficient stomach acid. Look at the fact that PPIs, PPI
• 45:46
  Speaker 3: drugs and antacids are amongst the most common pharmacy and
• 45:51
  Speaker 3: pharmaceutical products used in the US. You know, use a
• 45:54
  Speaker 3: PPI drug, you are cutting your acid in your stomach,
• 45:59
  Speaker 3: which you need to chemically digest food. He eat too quick,
• 46:03
  Speaker 3: you don't release then the pancreatic enzymes, the bile enzymes,
• 46:08
  Speaker 3: and everything else that are needed to digest your food. Properly.
• 46:11
  Speaker 3: If you eat your food while you are driving your car,
• 46:17
  Speaker 3: while you're watching CNN News looking at the latest things
• 46:20
  Speaker 3: that are happening in Israel or anywhere else in the world,
• 46:24
  Speaker 3: you are not going to be in rest and digest mode,
• 46:29
  Speaker 3: your parasympathetic autonomic side of your nervous system, and you
• 46:34
  Speaker 3: need to be in the parasympathetic mode. What happens is
• 46:37
  Speaker 3: that people in fight and flight mode on the simple
• 46:41
  Speaker 3: side of there, and you can't digest food properly.
• 46:44
  Speaker 1: And that's what people eat on the run, like you say,
• 46:47
  Speaker 1: or they're stressed out already and they're eating because they're stressed.
• 46:52
  Speaker 1: They're only fuel to the fire because the stress is
• 46:55
  Speaker 1: already fight or flight and the sympathetic nervous system is
• 46:59
  Speaker 1: on overdrive. Turned out, you're adding into that food that
• 47:03
  Speaker 1: are probably more carbs, not complex carbs or.
• 47:07
  Speaker 2: Regular starchy carves that.
• 47:09
  Speaker 1: You know, make it even more difficult to create the
• 47:13
  Speaker 1: insulin response.
• 47:15
  Speaker 3: Correct, So the mechanical breakdown if we look at say carbs, yes,
• 47:20
  Speaker 3: it's the amount of carbs, but you can look at
• 47:24
  Speaker 3: kids breakfast cereals that whole grain written on them. But
• 47:29
  Speaker 3: the whole grain is so mechanically processed. That if you
• 47:34
  Speaker 3: look at the you know, work of Jenny Brand Miller
• 47:38
  Speaker 3: from Professor Jenny Brown Miller from Sydney University. If you
• 47:41
  Speaker 3: go to glycemic index dot com, you can put in
• 47:45
  Speaker 3: the search bar and look at how we respond to
• 47:48
  Speaker 3: different foods and you'll find that those whole grain cereals
• 47:51
  Speaker 3: behave exactly like sugar if.
• 47:53
  Speaker 2: They are sugar. If you look at the ingredients, there's
• 47:57
  Speaker 2: all of them. Are almost all of them have you know,
• 48:01
  Speaker 2: a very high sugar.
• 48:02
  Speaker 3: Count exactly, but it's not even where the sugar count
• 48:06
  Speaker 3: is lower because of the degree of processing. Carbohydrate chains
• 48:12
  Speaker 3: are mechanically broken down their process. This is ultra processing.
• 48:16
  Speaker 3: So ultra process foods upfs are another big part of
• 48:19
  Speaker 3: the problem. So, and then coming back to the how
• 48:23
  Speaker 3: the other thing I wanted to say is, you know,
• 48:25
  Speaker 3: if you people know that the Mediterranean diet is healthy,
• 48:28
  Speaker 3: but it's also how people in the Mediterranean eat. They
• 48:31
  Speaker 3: take an hour off, they slip around a table, they
• 48:35
  Speaker 3: put on some nice music if it's in the evening,
• 48:38
  Speaker 3: they make up, got a candle on, and they move
• 48:42
  Speaker 3: themselves beautifully into parasympathetic mode. They exchange they're not looking
• 48:47
  Speaker 3: at the you know, CNN on the television at the
• 48:49
  Speaker 3: same time. So that's a big part of it. But
• 48:54
  Speaker 3: what about sitting. So you know, people say, oh, you
• 48:56
  Speaker 3: need to take more exercise, Well, sitting is the new smoking.
• 49:01
  Speaker 3: Sitting is one of the most dangerous things that we do.
• 49:04
  Speaker 3: We sit in the wrong way and if we if
• 49:06
  Speaker 3: you link that to posture, our posture, our muscular skeletal
• 49:13
  Speaker 3: system is falling apart. You know, Americans, the muscular skeletal system.
• 49:17
  Speaker 3: If you look at the work being done, you know,
• 49:20
  Speaker 3: in the field of advanced biostructural correction, it's extraordinary. How
• 49:26
  Speaker 3: you can I mean, this is a if you're like
• 49:29
  Speaker 3: a branch of chiropractic that's been essentially sidelined because it
• 49:35
  Speaker 3: is so effective and it basically runs against many of
• 49:38
  Speaker 3: the norms that are pushed out there that you can't
• 49:41
  Speaker 3: really do much about someone who's becoming chipotic. You know,
• 49:45
  Speaker 3: we see a bit upper part of the spine collapsing
• 49:48
  Speaker 3: because we're stuck in front of our comparisons.
• 49:51
  Speaker 1: And you know a lot of times I've kept to
• 49:54
  Speaker 1: catch myself as I'm looking down at.
• 49:56
  Speaker 2: My phone that you know, I phones in my hand
• 49:59
  Speaker 2: and I'm looking reading emails.
• 50:01
  Speaker 1: And I'm thinking, you know what your neck is going
• 50:05
  Speaker 1: to get completely you know what you look at what
• 50:08
  Speaker 1: you see when you see elderly people who have that
• 50:11
  Speaker 1: problem with their spine.
• 50:13
  Speaker 2: I forgot the name of it, but you know they're all.
• 50:16
  Speaker 3: Yeah, they got twists and the spine, which happens because
• 50:23
  Speaker 3: their vertebrae have basically fallen off the stack and then
• 50:26
  Speaker 3: that turns into kyphosis and they move forward in the
• 50:29
  Speaker 3: upper part cervical butt of there. So I'm talking to
• 50:33
  Speaker 3: you now standing I haven't sat at my and you
• 50:38
  Speaker 3: know it's yeah, it's easy to do, but we we
• 50:42
  Speaker 3: don't do it. Sitting is a really really dangerous thing
• 50:45
  Speaker 3: to do. But but physical exercise, I mean, American people
• 50:49
  Speaker 3: are way way too sedentary. Stress is another factor. You know,
• 50:55
  Speaker 3: if you're fearful about your financial situation, your relationships, you're
• 51:00
  Speaker 3: job prospects, that is a killer. Chemicals in the environment,
• 51:05
  Speaker 3: you know, we know chemicals in the food, but in
• 51:07
  Speaker 3: the air, in the water, you know, p fat chemicals,
• 51:12
  Speaker 3: forever chemicals, flora alcohol substances. These are organic fluorine compounds,
• 51:18
  Speaker 3: some of the most dangerous compounds around. Americans are being
• 51:21
  Speaker 3: absolutely loaded by them through the food We're pushing the
• 51:25
  Speaker 3: FDA to release more data. The last time it released
• 51:29
  Speaker 3: data was twenty nineteen. They're trying to argue that only
• 51:33
  Speaker 3: meats and seafood are contaminated with the pfas. We've done
• 51:38
  Speaker 3: testing of even kale and even organic kalet. It's all
• 51:44
  Speaker 3: contaminated and this stuff builds up in your body.
• 51:47
  Speaker 1: Well, recently they came out with protein powders, yes, the
• 51:52
  Speaker 1: p fassion, and you know, everybody thinks, oh, I'm taking
• 51:55
  Speaker 1: a protein powder. I must be doing the right thing
• 51:58
  Speaker 1: from my body, from my cargen and like lash gen.
• 52:02
  Speaker 1: And then they look and see these articles about now
• 52:05
  Speaker 1: they're full of forever chemicals.
• 52:08
  Speaker 3: Yeah, exactly, so chemicals. You know. I think another aspect
• 52:14
  Speaker 3: that increasingly is coming out of the field of clinical
• 52:20
  Speaker 3: psychology as well as clinical psychoeuroimmunology, is that our locus
• 52:28
  Speaker 3: of control, our ability to feel in control of our lives.
• 52:33
  Speaker 3: It turns out that is a really important health determinant.
• 52:38
  Speaker 3: And you know, social isolation is one of the biggest
• 52:44
  Speaker 3: less people get so sick, and they often people who
• 52:50
  Speaker 3: are socially isolated don't feel that they have control over
• 52:54
  Speaker 3: their lives. They're waiting for the States, someone else, their
• 52:57
  Speaker 3: doctor to control them. That is super unhealthy.
• 53:01
  Speaker 1: Well, that is the World Economic Forum. That is Claus
• 53:05
  Speaker 1: Schwab's vision. It's a totalitarian vision that we're you know,
• 53:09
  Speaker 1: we are going to be. You will own nothing and
• 53:12
  Speaker 1: you will be happy, and.
• 53:14
  Speaker 2: You will also be you know, under our thumb, under
• 53:20
  Speaker 2: our control.
• 53:20
  Speaker 3: So you will sign a social contract that makes sure
• 53:24
  Speaker 3: that you do. It's kind of like a hive mentality.
• 53:27
  Speaker 3: It turns human beings into you know, worker bees for
• 53:32
  Speaker 3: the system, and we're all working for the queen bee
• 53:35
  Speaker 3: in there exactly.
• 53:37
  Speaker 1: Well, so we're gonna be cut off here in a
• 53:40
  Speaker 1: little bit, I know, the time we go by very fast,
• 53:43
  Speaker 1: and just from Radfest and talking to you and Mel
• 53:47
  Speaker 1: and Phil Mickens and you know, our mutual friend and
• 53:50
  Speaker 1: you know, I just I when even you were you
• 53:55
  Speaker 1: were friends with Mark too, right from epic team.
• 53:59
  Speaker 3: Absolutely, yeah, yeah, absolutely, I'm just taking the products today, yeah,
• 54:04
  Speaker 3: rosales for years, yeah, yeah.
• 54:06
  Speaker 2: I Marcus, I take his epicy every day.
• 54:09
  Speaker 3: But levels are doing well.
• 54:12
  Speaker 2: Yeah. Yeah, it's a good thing, even for women. It's
• 54:14
  Speaker 2: a good thing.
• 54:16
  Speaker 1: But I knew that we would be able to talk forever,
• 54:18
  Speaker 1: because it's just you're just have so much knowledge and
• 54:21
  Speaker 1: so much experience.
• 54:22
  Speaker 2: But before we go, I know you've written a book, and.
• 54:26
  Speaker 1: Why don't you talk to us about that and your
• 54:29
  Speaker 1: little offer, not little, but your nice offer for our viewers.
• 54:33
  Speaker 3: Yeah.
• 54:33
  Speaker 5: Look, we we wrote a book a couple of years
• 54:37
  Speaker 5: ago called Reset Eating, and it's about resetting your metabolism
• 54:43
  Speaker 5: fundamentally so using food as medicine, and we take people
• 54:48
  Speaker 5: through a journey. It's got lots of pictures and images.
• 54:50
  Speaker 5: It takes the science that hopefully makes it pretty accessible
• 54:55
  Speaker 5: to people how you can without any drugs just by
• 54:59
  Speaker 5: changing what you're eating and when you're eating and how
• 55:02
  Speaker 5: you're eating to reset your metabolism. One of the goals,
• 55:07
  Speaker 5: you know, people think about what do you do with food?
• 55:11
  Speaker 5: While you eat healthy food, you try and reduce the calories.
• 55:15
  Speaker 5: What we say, what your goal should be is to
• 55:19
  Speaker 5: achieve what we call metabolic flexibility. It's a scientific concept
• 55:24
  Speaker 5: that basically means that you can use multiple fuels for energy,
• 55:30
  Speaker 5: so it means you can use carbs.
• 55:33
  Speaker 3: But of course, when we all did science as kids
• 55:36
  Speaker 3: at school and UNI, we learn about the crib cycle
• 55:39
  Speaker 3: and mitochondria and you remember just had carbohydrates feeding through consons,
• 55:45
  Speaker 3: you turn biruve into the mitochondria and then running through
• 55:49
  Speaker 3: electron transport to produce ATP. Well, the bottom line is
• 55:54
  Speaker 3: we can also use protein. So you know, this is
• 55:58
  Speaker 3: what's happening now with GLP receptor agonets, with weight loss jams.
• 56:04
  Speaker 3: You see the people with skinny arms, Well, what's happening
• 56:07
  Speaker 3: is they're consuming so little food that the body goes,
• 56:11
  Speaker 3: holy cow, where are we going to get energy from?
• 56:13
  Speaker 3: And it's burning muscle sopa is now, you know, accelerated sarcopenia,
• 56:20
  Speaker 3: age related muscle wastings being separated by these very very
• 56:24
  Speaker 3: dangerous But of course we can also burn fats. But
• 56:28
  Speaker 3: if you keep on consuming carbs, you literally put your
• 56:32
  Speaker 3: fat burning apparatus. The better oxidation of fatty acids go
• 56:36
  Speaker 3: through the liver. All of that just goes to sleep.
• 56:39
  Speaker 3: And of course we all store, you know, maybe half
• 56:43
  Speaker 3: a kilogram of glycogen, which is you know, the storage
• 56:48
  Speaker 3: form of glucose in our liver and our skeletal muscles.
• 56:51
  Speaker 3: So if you go along to the gym the fitness
• 56:55
  Speaker 3: suite and you try and take thirty minutes of exercise
• 56:58
  Speaker 3: every every day, you can put a tick in the box,
• 57:00
  Speaker 3: but all you'll be doing is burning that glycogen. So
• 57:04
  Speaker 3: we also teach people how you can combine strength training
• 57:09
  Speaker 3: together with more longer periods of activity. Human beings are
• 57:13
  Speaker 3: designed to be active ten hours a day. Behavior is
• 57:17
  Speaker 3: a big part of the reason why we got it wrong.
• 57:19
  Speaker 3: But this book is primarily about food. Reset Eating. We
• 57:23
  Speaker 3: would love to give away a copy now. One of
• 57:26
  Speaker 3: the reasons we can't give away many copies is basically
• 57:30
  Speaker 3: we're sold out. We are in the middle of a reprint.
• 57:33
  Speaker 3: We have a handful of copies sitting in our office
• 57:37
  Speaker 3: in the States, in Virginia. We will, happily the first
• 57:41
  Speaker 3: person is am I right that messages Michelle, they will
• 57:46
  Speaker 3: receive a signed copy of Reset Eating that is now
• 57:50
  Speaker 3: out of print. You'll see it on Amazon, and you'll
• 57:53
  Speaker 3: see it's temporarily off sale because we're waiting for the
• 57:57
  Speaker 3: reprint to go.
• 57:58
  Speaker 2: That is that is so generous And I know it's.
• 58:02
  Speaker 3: Dollars is the list price on Amazon?
• 58:04
  Speaker 1: Yeah, but it's a it's a bit, it's a real
• 58:07
  Speaker 1: it's a real generous offer to our viewers. And I
• 58:11
  Speaker 1: hope somebody who's watching right now gets on the phone
• 58:15
  Speaker 1: or gets on the email. My email is the th
• 58:19
  Speaker 1: and then my name M I C H E L
• 58:22
  Speaker 1: E h U G H T S and then company
• 58:26
  Speaker 1: spelled out singular at Gmail.
• 58:29
  Speaker 2: So whoever sends that email to me and they'll get
• 58:35
  Speaker 2: a sign copy, right.
• 58:36
  Speaker 3: You'll be able to sign it absolutely.
• 58:38
  Speaker 1: Autograph it, okay, perfect, and then once you get the
• 58:41
  Speaker 1: new ones in print, I'd love to get a copy.
• 58:44
  Speaker 1: I don't want to completely with a limited one now,
• 58:47
  Speaker 1: but I want to definitely read that book.
• 58:50
  Speaker 2: So all right, well, Rob, thank you so much for
• 58:53
  Speaker 2: coming on today. And I know it's a little bit
• 58:55
  Speaker 2: later there for you.
• 58:56
  Speaker 3: Right, it's it's it's approaching eight p I'm in the
• 59:00
  Speaker 3: evening for dinner time.
• 59:04
  Speaker 2: Yeah, I wanted today.
• 59:06
  Speaker 1: We'll have to have you back because I really wanted
• 59:08
  Speaker 1: you to share with everybody what your perfect day looks like,
• 59:12
  Speaker 1: because you're so knowledgeable about the.
• 59:14
  Speaker 2: Nutritional part and then of course the exercise.
• 59:17
  Speaker 1: And so at some point, maybe next because we're booked
• 59:20
  Speaker 1: through May of next year.
• 59:22
  Speaker 2: But sometime next year, if you would come back and
• 59:24
  Speaker 2: we will go into my work.
• 59:26
  Speaker 3: I'm a sixty five year old guy. I just have
• 59:29
  Speaker 3: my sixty fifth birthday.
• 59:31
  Speaker 2: You're amazing.
• 59:32
  Speaker 3: I'm not healthier than I've been at any other stage
• 59:34
  Speaker 3: of my life. So this idea that we have to
• 59:37
  Speaker 3: get less healthy as we get what we do is
• 59:41
  Speaker 3: we learn more about health, we learn how to drive
• 59:44
  Speaker 3: this incredibly sophisticated system human body and mind and spirit.
• 59:49
  Speaker 3: And that's what it's all about.
• 59:51
  Speaker 1: And a big part of it is attitude, because you know,
• 59:54
  Speaker 1: I just like every day I say thank you to
• 59:56
  Speaker 1: God for allowing me to be twenty years younger biological.
• 1:00:01
  Speaker 1: And I think people need to understand that biological age
• 1:00:04
  Speaker 1: is really the right measurement, not chronologue. That chronological is
• 1:00:09
  Speaker 1: just how many years you've gone around the sun. But
• 1:00:12
  Speaker 1: if your body is twenty years older than your chronological age,
• 1:00:15
  Speaker 1: you're in deep trouble.
• 1:00:17
  Speaker 2: But if your body is, you know, ten.
• 1:00:19
  Speaker 1: Twenty years younger, like I'm sure yours is, and you
• 1:00:22
  Speaker 1: look younger, you know, so you got it both ways.
• 1:00:26
  Speaker 3: Both the internal work now we've got we've got fantastic
• 1:00:29
  Speaker 3: tools like true diagnostics. You know, I was just going
• 1:00:33
  Speaker 3: to tell you I.
• 1:00:33
  Speaker 1: Just finished my true Diagnostics test. So Ryan is a
• 1:00:37
  Speaker 1: good friend of mine. I adore him and Ryan Smith
• 1:00:41
  Speaker 1: and he's been on my podcast. So yeah, so I'll
• 1:00:43
  Speaker 1: be getting those results. It'll be my third or second
• 1:00:47
  Speaker 1: time doing their test. And then I did the telomere
• 1:00:50
  Speaker 1: test with the spectro cell. So the pla mare length
• 1:00:54
  Speaker 1: is another measurement of your biological age. And then DNA
• 1:00:58
  Speaker 1: the DNA company at a Toronto does your epigenetic DNAs.
• 1:01:03
  Speaker 1: It also gives you a measurement of So there's there's
• 1:01:06
  Speaker 1: so much technology today.
• 1:01:08
  Speaker 2: That tells you guides you, uh.
• 1:01:11
  Speaker 1: And then and then all the other tools like photo
• 1:01:13
  Speaker 1: biomodulation and and no red light therapy, I mean, and
• 1:01:18
  Speaker 1: other other therapies.
• 1:01:20
  Speaker 2: I just got Weber Medical.
• 1:01:22
  Speaker 1: I don't know if you know them out of uh,
• 1:01:24
  Speaker 1: they're out of Germany. Robert Weber, Yes, and he just
• 1:01:29
  Speaker 1: sent me his watch and that you know, you use
• 1:01:32
  Speaker 1: that a couple three times a day and it puts
• 1:01:35
  Speaker 1: it's a laser technology.
• 1:01:36
  Speaker 2: So there are a real medical device.
• 1:01:38
  Speaker 1: Company, not a consumer although they're you know, their watch
• 1:01:42
  Speaker 1: is now addressing the consumer market. But yeah, there's so
• 1:01:45
  Speaker 1: much available today to be able to not only measure,
• 1:01:50
  Speaker 1: but to practice and to feel the results with the
• 1:01:55
  Speaker 1: help of these aids that are are out there.
• 1:01:59
  Speaker 2: And we didn't even get into the.
• 1:02:01
  Speaker 1: Brain that you know the gut bring access and how
• 1:02:04
  Speaker 1: how much knowledge it helps to improve those.
• 1:02:08
  Speaker 3: Two get the verigal turns sorded. And of course this
• 1:02:12
  Speaker 3: is what if you look at I. E. Vader or
• 1:02:15
  Speaker 3: traditional Chinese medicine. They understood the relationship between the gut
• 1:02:19
  Speaker 3: brain connection and they own, you know, centuries ago. So
• 1:02:24
  Speaker 3: we're catching up in the West before we.
• 1:02:26
  Speaker 1: Say goodbye, would you just give us your website so
• 1:02:28
  Speaker 1: people can look at your alliance.
• 1:02:31
  Speaker 3: So I'll give you two websites, so we'll give our us.
• 1:02:35
  Speaker 3: One is very much focused on the political work that
• 1:02:38
  Speaker 3: we do. Is we we have calls to action all
• 1:02:42
  Speaker 3: the time, to congress, to different government agencies. We are
• 1:02:48
  Speaker 3: you know, we're launching legal campaigns and initiatives all the time, lawsuits,
• 1:02:55
  Speaker 3: et cetera. So that is a n H which stands
• 1:02:58
  Speaker 3: for Alliance for Natural Health, a n H dash U
• 1:03:03
  Speaker 3: s a dot org. So a n h U s
• 1:03:06
  Speaker 3: a dot org. If you want more information on the
• 1:03:09
  Speaker 3: health side, to our international website, which is a n
• 1:03:14
  Speaker 3: H no dash at a n H International dot.
• 1:03:18
  Speaker 2: Org international spelled out.
• 1:03:20
  Speaker 3: Spelled out in full H International dot org and both
• 1:03:24
  Speaker 3: of them have weekly newsletters that you can sign up
• 1:03:27
  Speaker 3: to correctly. So there's a load of information coming through
• 1:03:32
  Speaker 3: through both of them. I would urge you to to
• 1:03:34
  Speaker 3: sign up to both.
• 1:03:35
  Speaker 2: Awesome, okay, Rob, Well, have a good dinner.
• 1:03:39
  Speaker 3: Thank you so much. Michelle's such a pleasure to see
• 1:03:42
  Speaker 3: you go.
• 1:03:44
  Speaker 2: Are you going to be at a forum or you know?
• 1:03:47
  Speaker 3: Do you know? I'm Our schedule is so tight at
• 1:03:51
  Speaker 3: the moment, there's no whether I will or I won't,
• 1:03:55
  Speaker 3: but I think I yeah.
• 1:03:59
  Speaker 1: Now I always go with Phil. Wherever Phil goes. I
• 1:04:05
  Speaker 1: like to know because each the way.
• 1:04:07
  Speaker 2: All right, Well, very good, take care Okay tears m